1. Home
  2. NAII vs HBIO Comparison

NAII vs HBIO Comparison

Compare NAII & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • HBIO
  • Stock Information
  • Founded
  • NAII 1980
  • HBIO 1901
  • Country
  • NAII United States
  • HBIO United States
  • Employees
  • NAII N/A
  • HBIO 355
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • NAII Health Care
  • HBIO Industrials
  • Exchange
  • NAII Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • NAII 21.1M
  • HBIO 19.6M
  • IPO Year
  • NAII 1987
  • HBIO 2000
  • Fundamental
  • Price
  • NAII $3.25
  • HBIO $0.45
  • Analyst Decision
  • NAII
  • HBIO Buy
  • Analyst Count
  • NAII 0
  • HBIO 2
  • Target Price
  • NAII N/A
  • HBIO $3.00
  • AVG Volume (30 Days)
  • NAII 4.8K
  • HBIO 2.2M
  • Earning Date
  • NAII 05-14-2025
  • HBIO 08-07-2025
  • Dividend Yield
  • NAII N/A
  • HBIO N/A
  • EPS Growth
  • NAII N/A
  • HBIO N/A
  • EPS
  • NAII N/A
  • HBIO N/A
  • Revenue
  • NAII $125,483,000.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • NAII N/A
  • HBIO N/A
  • Revenue Next Year
  • NAII N/A
  • HBIO $9.75
  • P/E Ratio
  • NAII N/A
  • HBIO N/A
  • Revenue Growth
  • NAII 4.39
  • HBIO N/A
  • 52 Week Low
  • NAII $2.57
  • HBIO $0.28
  • 52 Week High
  • NAII $6.88
  • HBIO $3.60
  • Technical
  • Relative Strength Index (RSI)
  • NAII 45.04
  • HBIO 47.75
  • Support Level
  • NAII $3.21
  • HBIO $0.42
  • Resistance Level
  • NAII $3.49
  • HBIO $0.55
  • Average True Range (ATR)
  • NAII 0.10
  • HBIO 0.05
  • MACD
  • NAII -0.03
  • HBIO -0.01
  • Stochastic Oscillator
  • NAII 12.90
  • HBIO 18.75

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: